Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist
Eascra Biotech has appointed Dr. Anne Yau as a Life Science Research Scientist to advance RNA therapeutics for musculoskeletal diseases using Janus base nanoparticle platforms. Dr. Yau will work at the company's preclinical lab within the Massachusetts Biomedical Initiatives facility in Worcester, Massachusetts.
Eascra Biotech, a nanomedicine startup, has named Dr. Anne Yau as a Life Science Research Scientist. Dr. Yau will work at the company's preclinical lab in Worcester, Massachusetts, within the Massachusetts Biomedical Initiatives facility. She brings nine years of experience in pharmaceutical R&D, nanomedicine, and advanced cell-based model development. Dr. Yau's research focused on developing Janus base nanomaterial platforms for cartilage repair and regeneration. Eascra Biotech is developing RNA therapeutics for hard-to-treat conditions, including osteoarthritis and musculoskeletal diseases. The company's Janus Base Nanoparticle technology delivers therapeutics to hard-to-penetrate tissues and maintains fragile cargos like mRNA at room temperature.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.